We are live on
!
Find out more
EHWM
Eads & Heald Wealth Management Portfolio holdings
AUM
$201M
1-Year Est. Return
21.29%
This Fund
S&P 500
This Quarter
Est. Return
+10.53%
1 Year Est. Return
+21.29%
3 Year Est. Return
+70.18%
5 Year Est. Return
+104.01%
10 Year Est. Return
+364.64%
AUM
$186M
AUM Growth
+$18.5M
(+11%)
Cap. Flow
+$2.6M
Cap. Flow
% of AUM
1.4%
Top 10 Holdings %
Top 10 Hldgs %
16.33%
Holding
136
New
11
Increased
60
Reduced
52
Closed
4
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Salesforce
CRM
|
+$1.08M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$609K |
| 3 |
Mondelez International
MDLZ
|
+$556K |
| 4 |
J.M. Smucker
SJM
|
+$419K |
| 5 |
Unilever
UL
|
+$405K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UN
Unilever NV New York Registry Shares
UN
|
+$370K |
| 2 |
Idexx Laboratories
IDXX
|
+$269K |
| 3 |
Nike
NKE
|
+$236K |
| 4 |
Principal Financial Group
PFG
|
+$234K |
| 5 |
ExxonMobil
XOM
|
+$234K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.15% |
| 2 | Healthcare | 17.44% |
| 3 | Industrials | 14.91% |
| 4 | Consumer Discretionary | 13.06% |
| 5 | Consumer Staples | 12.54% |
Similar funds
LI
FFL
SWIA
FCM
FIA
SA
FFC
RM
Eads & Heald Wealth Management's Q4 2020 Portfolio in Review
As of Q4 2020, Eads & Heald Wealth Management held 136 positions worth $186M, up 11% from $167M the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Eads & Heald Wealth Management's Q4 2020 filing shows 11 new, 60 increased, 52 reduced and 4 closed positions. Its largest new stake was Salesforce: 4,449 shares worth $990K. The largest sale was Unilever NV New York Registry Shares, an estimated $370K.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Healthcare and Industrials.
- Eads & Heald Wealth Management's largest Q4 2020 buy was Salesforce: 4,449 shares worth $990K.
- Eads & Heald Wealth Management added most to Bristol-Myers Squibb in Q4 2020, an estimated $609K increase.
- Eads & Heald Wealth Management's biggest Q4 2020 reduction was Idexx Laboratories, cutting an estimated $269K.
- Eads & Heald Wealth Management fully exited Unilever NV New York Registry Shares in Q4 2020, selling an estimated $370K.
- Eads & Heald Wealth Management's ten largest holdings make up 16% of its $186M portfolio in Q4 2020.
- Eads & Heald Wealth Management opened 11 new positions and closed 4 in Q4 2020.
- Eads & Heald Wealth Management's portfolio value rose 11% quarter-over-quarter to $186M.
Based on Eads & Heald Wealth Management's 13F filing for Q4 2020, filed 2 Feb 2021.